Ibnsina Pharma (EGX:ISPH)
Egypt · Delayed Price · Currency is EGP 10.46
-0.04 (-0.38%)
At close: Mar 15, 2026
Ibnsina Pharma Cash Flow Statement
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 951.98 | 614.56 | 213.66 | 172.58 | 314.73 |
Depreciation & Amortization | 319.77 | 242.2 | 184.22 | 182.53 | 175.34 |
Other Amortization | 28.99 | 23.53 | 6.57 | 5.64 | 2.75 |
Loss (Gain) From Sale of Assets | -71.51 | -2.95 | -1.39 | -1.21 | -4.25 |
Loss (Gain) From Sale of Investments | -0.32 | - | - | - | - |
Loss (Gain) on Equity Investments | - | -1.56 | 1.13 | - | - |
Provision & Write-off of Bad Debts | 16.81 | 215.37 | 83.85 | 65.53 | -45.13 |
Other Operating Activities | 355.58 | 407.75 | 173.02 | -41.75 | 88.58 |
Change in Accounts Receivable | -5,276 | -6,643 | -4,068 | -85.2 | -1,284 |
Change in Inventory | -1,644 | -3,578 | -671.73 | -400.14 | -194.15 |
Change in Accounts Payable | 5,555 | 8,151 | 4,386 | 558.68 | 697.3 |
Change in Other Net Operating Assets | -307.05 | -356.43 | -181.75 | -94.79 | -91.78 |
Operating Cash Flow | -71.06 | -926.58 | 125.81 | 361.88 | -340.43 |
Operating Cash Flow Growth | - | - | -65.23% | - | - |
Capital Expenditures | -734.6 | -260.05 | -354.04 | -798.46 | -147.53 |
Sale of Property, Plant & Equipment | 179.2 | 23.4 | 82.45 | 50.45 | 16.01 |
Sale (Purchase) of Intangibles | -38.17 | -22.89 | -8.23 | -26.18 | -11.15 |
Investment in Securities | -54.68 | - | - | - | - |
Other Investing Activities | - | - | - | -601.86 | - |
Investing Cash Flow | -648.26 | -259.54 | -279.82 | -1,376 | -142.67 |
Short-Term Debt Issued | 790.33 | 1,214 | 875.52 | 721.63 | 960.4 |
Long-Term Debt Issued | 636.45 | 577.29 | 362.57 | 712.39 | - |
Total Debt Issued | 1,427 | 1,791 | 1,238 | 1,434 | 960.4 |
Long-Term Debt Repaid | -422.09 | -874.29 | -471.63 | -21.53 | -250.65 |
Total Debt Repaid | -422.09 | -874.29 | -471.63 | -21.53 | -250.65 |
Net Debt Issued (Repaid) | 1,005 | 916.87 | 766.46 | 1,412 | 709.75 |
Issuance of Common Stock | - | - | - | 0.49 | - |
Repurchase of Common Stock | - | - | - | -185.74 | -14.4 |
Common Dividends Paid | -201.04 | -25.62 | -22.94 | -140.4 | -14.59 |
Financing Cash Flow | 803.65 | 891.25 | 743.52 | 1,087 | 680.77 |
Net Cash Flow | 84.33 | -294.87 | 589.52 | 72.67 | 197.66 |
Free Cash Flow | -805.66 | -1,187 | -228.23 | -436.58 | -487.96 |
Free Cash Flow Margin | -1.05% | -2.13% | -0.67% | -1.96% | -2.25% |
Free Cash Flow Per Share | -0.80 | -1.18 | -0.23 | -0.43 | -0.38 |
Cash Interest Paid | 2,271 | 1,375 | 929.98 | 481.52 | 281.54 |
Cash Income Tax Paid | 55.38 | - | - | - | 76.32 |
Levered Free Cash Flow | -6,381 | -7,044 | -2,724 | -1,495 | -617.13 |
Unlevered Free Cash Flow | -4,782 | -5,990 | -2,071 | -1,197 | -439.52 |
Change in Working Capital | -1,672 | -2,425 | -535.24 | -21.45 | -872.44 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.